BDRX
Biodexa Pharmaceuticals Plc
NASDAQ · Healthcare · Biotechnology · GB
$0.39
−14.36%Next report
Analyst consensus
- Next report date
- Apr 23, 2027
- EPS estimate
- —
- Revenue estimate
- —
Latest reported
- Last report date
- Sep 12, 2025
- EPS actual
- -$205.3K
- EPS estimate
- -$0.00
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 2
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- -1723481041.5%
- Revenue beats (12Q)
- —
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Sep 12, 2025 | -$0.00 | -$205.3K | Miss -5170443309.07% | — |
| Apr 11, 2025 | -$0.01 | -$0.00 | Beat 92.21% | — |
| Sep 26, 2024 | -$0.22 | -$0.02 | Beat 92.44% | — |
| Sep 15, 2023 | — | -$5.83 | — | $377.4K |
| Apr 23, 2019 | — | -$2.1K | — | $1.9M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Apr 23, 2027